May 27, 2025 / 12:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Bioline RX. First-quarter 2025 financial results conference call. (Operator Instructions) I would now like to turn over the call to Irena Kofler, Investor Relations. Irena, please go ahead. Thank.
Irina Koffler - BioLine RX Ltd - Investor Relations
Operator, and welcome everyone. Thank you for joining us on our quarterly results conference call. Earlier today, we issued a press release, a copy of which is available in the investor relations section of our website. It was also filed as a 6-K.
I'd like to remind you that certain statements we make during the call will be forward-looking.
Because such statements deal with future events and are subject to many risks and uncertainties, actual results may differ materially from those in the forward-looking statements. For a full discussion of these risks and uncertainties, please review our annual report on Form 2-Q and our quarterly reports on Form 6K that are filed with the US Securities and Exchange Commission. At this time, it is now my
Q1 2025 BioLine RX Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
